Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/vermindering-in-hormoonsubstitutie-eZcLc75qqX
References (14)
-
M. Garton (2003)
Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 362
-
J. Rossouw, G. Anderson, Ross Prentice, Andrea LaCroix, C. Kooperberg, M. Stefanick, R. Jackson, Shirley Beresford, Barbara Howard, Karen Johnson, J. Kotchen, Judith Ockene (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.JAMA, 288 3
-
J. Rymer, Ruthy Wilson, K. Ballard (2003)
Making decisions about hormone replacement therapyBMJ : British Medical Journal, 326
-
E. Grant (2011)
Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.Journal of the National Cancer Institute, 103 13
-
T. Lagro-Janssen, W. Rosser, C. Weel (2003)
Breast cancer and hormone-replacement therapy: up to general practice to pick up the piecesThe Lancet, 362
-
C. Weel (1995)
Validating long term morbidity recording.Journal of Epidemiology and Community Health, 49
-
JE Rossouw, GL Anderson, RL Prentice, AZ LaCroix, C Kooperberg, ML Stefanick (2002)
Writing Group for the Womens’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomised controlled trialJAMA, 288
-
M. Canonico, G. Plu-Bureau, G. Lowe, P. Scarabin (2008)
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysisBMJ : British Medical Journal, 336
-
Anne Taylor, A. Maclennan, J. Avery (2006)
Postmenopausal hormone therapy: Who now takes it and do they differ from non‐users?Australian and New Zealand Journal of Obstetrics and Gynaecology, 46
-
F. Grodstein, J. Manson, M. Stampfer, K. Rexrode (2008)
Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy.Archives of internal medicine, 168 8
-
(1998.)
International Classification of Primary Care, ICPC-2. -
K. Canfell, E. Banks, A. Moa, V. Beral (2008)
Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in AustraliaMedical Journal of Australia, 188
-
B. Bentsen (1986)
International classification of primary care.Scandinavian journal of primary health care, 4 1
-
G. Heiss, R. Wallace, G. Anderson, A. Aragaki, S. Beresford, R. Brzyski, R. Chlebowski, M. Gass, A. LaCroix, J. Manson, R. Prentice, J. Rossouw, M. Stefanick (2008)
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.JAMA, 299 9
- Publisher
- Springer Journals
- Copyright
- Copyright © 2011 by Bohn, Stafleu van Loghum
- Subject
- Medicine & Public Health; Medicine/Public Health, general
- ISSN
- 0018-7070
- eISSN
- 1876-5912
- DOI
- 10.1007/s12445-011-0234-5
- Publisher site
- See Article on Publisher Site
Abstract
Lagro-Janssen ALM, Knufing MWA, Schreurs L, Van Weel C. Vermindering in de hormoonsubstitutie. Huisarts Wet 2011;54(9):484-7.
Journal
Huisarts en wetenschap – Springer Journals
Published: Nov 9, 2011